View Report Summary
View Report SummaryGlobal medical loupes market is anticipated to grow at CAGR of 6.97% through 2027 on account of rising number of minimally invasive surgeries and chronic ailments across the globe. Increasing number of surgeries would require the extensive use of medical instruments which is somehow directly proportional to the utilization of medical loupes.
According to the United Nations Department of Economic and Social Affairs, Population Division, the number of people aged 65 years or above was about 702.9 million in 2019. This number is expected to grow by 120% and will reach to 1548.9 million by 2050.
Based on the type, medical loupes market is split into headband mounted, flip-up loupes, clip on loupes, and through the lens (TTL) loupes. Through-the-lens (TTL) segment is expected to register the fastest growth during the forecast period. This can be ascribed to the rising need for personalized loupes as per the end user requirements for better feasibility and improved quality of work. An increase in use of minimally invasive surgical instruments has been witnessed in various cardiovascular procedures especially for the coronary and percutaneous cardiology interventions on account of the various benefits associated with minimally invasive surgical procedures.
Some of the companies operating in the medical lopes market include Carl Zeiss Meditec AG, Univet S.r.l, Heine Optotechnik GmbH & Co. KG, Envista Holdings Corporation (Orascoptic), and Halma Plc (Keeler Limited).